Please visit the Myelodysplastic Syndromes (MDS) Research Fund page for more information.
Brigham and Women’s Hospital
Dissecting the Contribution of Mutated T Cells to Inflammation in Clonal Hematopoiesis and Myelodysplastic Syndromes 2023 Overview The Vera and Joseph Dresner Foundation granted Brigham…
Albert Einstein College of Medicine
Interrogation of germline genetic risk of clonal hematopoiesis 2023 Overview Albert Einstein College of Medicine was awarded a $250,000 grant over two years to support…
University of Washington
The role of EBIs in the pathogenesis of MDS anemia 2023 Overview The Vera and Joseph Dresner Foundation granted the University of Washington a $500,000…
University of Rochester
The role of the stem cell niche in the progression of myelodysplastic syndromes (MDS) to secondary acute myeloid leukemia (sAML) 2022 Overview University of Rochester…
Massachusetts General Hospital
Dissecting the Biology of the DNA Damage Response Genes TP53 and PPM1D in Myelodysplastic Syndrome 2022 Overview The Vera and Joseph Dresner Foundation granted Massachusetts…
Cincinnati Children’s Hospital Medical Center
Clonal and Microenvironment Crosstalk in DDX41-Mutant MDS 2022 Overview Cincinnati Children’s Hospital Medical Center was awarded a $250,000 grant over two years to support early…
City of Hope
A novel strategy to prevent malignant transformation of MDS 2022 Overview The Vera and Joseph Dresner Foundation granted City of Hope a $500,000 grant over…
University of Pennsylvania
Role of the “Immunome” in response and failure of allogeneic stem cell transplantation for MDS 2021 Overview The Vera and Joseph Dresner Foundation granted University…
St. Jude Children’s Research Hospital
Elucidating mechanisms of genomic rescue in SAMD9/SAMD9L-related MDS predisposition 2021 Overview St. Jude Children’s Research Hospital was awarded a $250,000 grant over two years to…
University of Texas – MD Anderson Cancer Center
The role of HIPK2 in the pathogenesis of therapy-related myelodysplastic syndrome with del7q 2021 Overview The Vera and Joseph Dresner Foundation granted University of Texas…
Johns Hopkins University
The Role of Short Telomeres in Age-Related Myelodysplastic Syndromes 2020 Overview The Vera and Joseph Dresner Foundation granted Johns Hopkins University a $250,000 grant over…
Fred Hutchinson Cancer Research Center
Therapeutic Targeting of Aberrant mRNA Splicing in Myelodysplastic Syndromes 2020 Overview Fred Hutchinson Cancer Research Center was awarded a $250,000 grant over two years to…
Yale University
Exploiting DNA Repair Defects in IDH Mutant MDS via Combination Therapies 2020 Overview The Vera and Joseph Dresner Foundation granted Yale University a $500,000 grant…
Memorial Sloan-Kettering Cancer Center
Phase II Study of a Geriatric Vulnerability Based, Personalized Allogeneic Hematopoietic Transplantation Strategy for Older, Vulnerable Patients with Myelodysplastic Syndrome. 2019 Overview Memorial Sloan-Kettering Cancer…
The Cleveland Clinic Foundation
The Role of DDX41 in MDS 2019 Overview The Vera and Joseph Dresner Foundation granted The Cleveland Clinic Foundation a $500,000 grant over two years…
University of Miami
Targeted Maintenance of TET Activity in MDS Progression and Treatment 2019 Overview The Vera and Joseph Dresner Foundation granted University of Miami a $250,000 grant…
H. Lee Moffitt Cancer Center
Delineation of Immune Evasive Mechanisms Driving Poor Outcome in TP53 Mutant Myelodysplatic Syndromes 2018 Overview The Vera and Joseph Dresner Foundation granted H Lee Moffitt…
The Cleveland Clinic Foundation
Molecularly targeted agents in myelodysplastic syndrome 2018 Overview The Vera and Joseph Dresner Foundation granted The Cleveland Clinic Foundation a $250,000 grant for early career…
University of Rochester
Role for bone marrow mesenchymal populations in modulating Interleukin 1 signaling in myelodysplastic syndrome 2018 Overview The Vera and Joseph Dresner Foundation granted University of…
Dana-Farber Cancer Institute
A New Paradigm of Transfusion Support for Patients with Myelodysplastic Syndromes 2017 Overview The Dresner Foundation granted Dana-Farber Cancer Institute a $500,000 grant for established…
Dana-Farber Cancer Institute
The Impact of Somatic STAG2 Mutations on MDS Transformation in GATA2 Deficiency Syndrome 2017 Overview Dana-Farber Cancer Institute received a $287,500 grant to support early…
Memorial Sloan-Kettering Cancer Center
The Clinical Impact of MDS Stem Cells in Patients Undergoing Allogeneic Transplant 2017 Overview Memorial Sloan-Kettering Cancer Center was awarded a $287,500 grant to support…